NIFTY 50

Biocon Q3 earnings today: Here's what to expect

Updated : January 24, 2019 12:24 PM IST

Indian biopharmaceutical company Biocon is set to report its third quarter results on Thursday. Here are key factors to watch out for:

  • It is expected to be a strong quarter for the company.
  • The revenue is likely to grow around 30 percent.
  • Margin expansion of around 400 basis points seen, led by higher margin products. One basis point is a hundredth of a percentage point.
  • Profit is expected to see a growth of 79 percent.
  • Within the biosimilar business, the one thing which is going to drive growth will be the launch of Pegfilgrastim in the US, the cancer biosimilar.
  • Branded formulation segment is likely to follow biologics with strong growth of 20-25 percent.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you